The NLRP3 inflammasome was demonstrated to promote the pathogenesis and progression of various liver diseases such as viral hepatitis, NASH, hepatic fibrosis, cirrhosis, and HCC [7]. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.